- Home
- CTSO vs XPL Comparison
CTSO vs XPL Comparison
Compare CTSO & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- XPL
- Stock Information
- Founded
- CTSO 1997
- XPL 1984
- Country
- CTSO United States
- XPL United States
- Employees
- CTSO N/A
- XPL N/A
- Industry
- CTSO Medical/Dental Instruments
- XPL Precious Metals
- Sector
- CTSO Health Care
- XPL Basic Materials
- Exchange
- CTSO Nasdaq
- XPL Nasdaq
- Market Cap
- CTSO 52.6M
- XPL 47.9M
- IPO Year
- CTSO N/A
- XPL N/A
- Fundamental
- Price
- CTSO $1.18
- XPL $0.64
- Analyst Decision
- CTSO Buy
- XPL Strong Buy
- Analyst Count
- CTSO 2
- XPL 1
- Target Price
- CTSO $5.50
- XPL $1.20
- AVG Volume (30 Days)
- CTSO 99.9K
- XPL 194.8K
- Earning Date
- CTSO 08-12-2025
- XPL 07-29-2025
- Dividend Yield
- CTSO N/A
- XPL N/A
- EPS Growth
- CTSO N/A
- XPL N/A
- EPS
- CTSO N/A
- XPL N/A
- Revenue
- CTSO $35,332,238.00
- XPL N/A
- Revenue This Year
- CTSO $18.34
- XPL N/A
- Revenue Next Year
- CTSO $19.82
- XPL N/A
- P/E Ratio
- CTSO N/A
- XPL N/A
- Revenue Growth
- CTSO 15.37
- XPL N/A
- 52 Week Low
- CTSO $0.70
- XPL $0.54
- 52 Week High
- CTSO $1.61
- XPL $0.98
- Technical
- Relative Strength Index (RSI)
- CTSO 67.21
- XPL 45.32
- Support Level
- CTSO $1.03
- XPL $0.65
- Resistance Level
- CTSO $1.29
- XPL $0.69
- Average True Range (ATR)
- CTSO 0.09
- XPL 0.03
- MACD
- CTSO 0.02
- XPL -0.00
- Stochastic Oscillator
- CTSO 75.45
- XPL 22.92
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About XPL Solitario Resources Corp.
Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.